LOS ANGELES: vTv Therapeutics, a biotech developing treatments for Alzheimer’s disease and type 2 diabetes, announced terms for its IPO on Monday.
The High Point, NC-based company plans to raise capital by offering 7.8 million shares.
vTv Therapeutics was founded in 1999. It initially filed confidentially on May 14, 2015. Piper Jaffray and Stifel are the joint bookrunners on the deal. It is expected to price during the week of July 27, 2015.